Compare EHTH & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EHTH | AQST |
|---|---|---|
| Founded | 1997 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.0M | 521.0M |
| IPO Year | 2006 | 2007 |
| Metric | EHTH | AQST |
|---|---|---|
| Price | $1.50 | $4.12 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $3.33 | ★ $9.00 |
| AVG Volume (30 Days) | 1.0M | ★ 1.9M |
| Earning Date | 05-06-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.43 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $251,395,000.00 | $67,430,000.00 |
| Revenue This Year | N/A | $14.23 |
| Revenue Next Year | $5.18 | $58.36 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 45.86 | 0.77 |
| 52 Week Low | $1.20 | $2.20 |
| 52 Week High | $7.56 | $7.55 |
| Indicator | EHTH | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 38.14 | 50.07 |
| Support Level | $1.20 | $3.69 |
| Resistance Level | $1.93 | $4.46 |
| Average True Range (ATR) | 0.15 | 0.21 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 41.20 | 39.84 |
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.